Efficacy of minimal residual disease driven immune-intervention after allogeneic hematopoietic stem cell transplantation for high-risk chronic lymphocytic leukemia: results of a prospective multicentric trial. (2020)

First Author: Tournilhac O
Attributed to:  Transcriptional Regulation of GATA-1 funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3324/haematol.2019.239566

PubMed Identifier: 32527951

Publication URI: http://europepmc.org/abstract/MED/32527951

Type: Journal Article/Review

Parent Publication: Haematologica

ISSN: 0390-6078